Infliximab

Details

Files

Generic Name:

Infliximab

Project Status:

Withdrawn

Therapeutic Area:

Ankylosing spondylitis; arthritis, psoriatic; arthritis, rheumatoid; plaque psoriasis

Manufacturer:

Fresenius Kabi Canada

Call for patient/clinician input open:

July 15, 2014

Brand Name:

Remsima

Project Line:

Reimbursement Review

Project Number:

SE0383-000

Call for patient/clinician input closed:

September 4, 2014

Biosimilar:

Yes

Submission Type:

Initial

Indications:

Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis

Last Updated : May 30, 2014